Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of osteoporotic fractures in patients with newly diagnosed pemphigus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Impact of semaglutide pretreatment on reproductive outcomes in women with overweight and obesity with infertility: a real-world multicenter cohort study.

Reproductive biology and endocrinology : RB&E·2026
Same author

Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.

Therapeutic advances in musculoskeletal disease·2026
Same author

Downstream Treatment Burden and Health-Care Utilization Following Initiation of GLP-1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes.

Diabetes, obesity & metabolism·2026
Same author

Association Between Gout and the Risk of Dementia: A Meta-Analysis of Observational Studies and Biological Mechanisms.

International journal of rheumatic diseases·2026
Same author

Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same journal

Stakeholder Experiences With the Pneumococcal Conjugate Vaccine Chatbot as a Complementary Capacity-Building Tool for Frontline Health Workers in India: Qualitative Study.

JMIR formative research·2026
Same journal

Acceptability and Perceived Usefulness of a Digital Gambling Harm Minimisation Tool: A Cross-Sectional Study.

JMIR formative research·2026
Same journal

Knowledge Graphs Based on Meta-Analysis Papers Improve the Quality of Case Formulation: Mixed Methods Design.

JMIR formative research·2026
Same journal

Expedited Transition to Digital Delivery of Recovery Support Services Due to the COVID-19 Pandemic: Mixed Methods Needs Assessment.

JMIR formative research·2026
Same journal

Impact of an mHealth App on Digital Transformation: Randomized Clinical Trial on Strengthening Digital Skills in Older Women.

JMIR formative research·2026
Same journal

Emotion Classification in Japanese Cancer Survivor Interview Narratives Using Sentiment Polarity and Plutchik Emotion Frameworks: Model Development and Evaluation Study.

JMIR formative research·2026
See all related articles

Related Experiment Videos

Interpretable Machine Learning Framework for Predicting Major Adverse Cardiovascular Events in Rheumatoid Arthritis

Wei-Chen Chiang1, Guan-Ling Lin1, Yu-Sheng Chang2,3

  • 1Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, 9F, Education and Research Building, Shuang Ho Campus No. 301, Yuantong Rd, Zhonghe Dist, New Taipei, 235, Taiwan, 886 2-6620-2589 ext 10927.

JMIR Formative Research
|June 5, 2026
PubMed
Summary
This summary is machine-generated.

Interpretable machine learning models can predict cardiovascular events in rheumatoid arthritis (RA) patients. Random Survival Forest with SHAP analysis offers transparent, personalized risk insights for better RA management.

Keywords:
Cox-TimeDeepSurvMACEsSHAPShapley additive explanationsinterpretable machine learningmajor adverse cardiovascular eventsrandom survival forestrheumatoid arthritis

Related Experiment Videos

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Artificial Intelligence in Healthcare

Background:

  • Patients with rheumatoid arthritis (RA) have an elevated risk of major adverse cardiovascular events (MACE).
  • The clinical utility of machine learning (ML) for cardiovascular risk prediction in RA is limited by the "black-box" nature of complex algorithms.

Purpose of the Study:

  • To develop interpretable survival models for predicting MACE in RA patients.
  • To provide transparent and actionable insights for personalized cardiovascular risk management in RA.

Main Methods:

  • Utilized data from 2461 RA patients (2011-2022) from the Taipei Medical University Clinical Research Database.
  • Compared ML survival models (Random Survival Forest, DeepSurv, Cox-Time) against the Cox proportional hazards model.
  • Integrated permutation importance and SHAP (Shapley additive explanations) for model interpretability.

Main Results:

  • Random Survival Forest (RSF) exhibited superior performance (C-index: 0.8771, integrated Brier score: 0.0775).
  • Key predictors identified include creatinine, conventional synthetic disease-modifying antirheumatic drugs, C-reactive protein, alanine aminotransferase, and age at RA diagnosis.
  • SHAP analysis revealed specific protective and risk-increasing effects of medications and laboratory markers.

Conclusions:

  • RSF with SHAP analysis provides interpretable and personalized cardiovascular risk predictions for RA patients.
  • This approach enhances clinical decision-making and advances precision medicine in rheumatology.
  • Future research should focus on temporal and external validation to ensure model generalizability.